Home / Data / Women's Health Trial Tracker Women's Health Trial Tracker Women's Health Trial Tracker organizes records from ClinicalTrials.gov API v2 into a static table for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
Records 5,000
Last changed 10/10/2026
Update schedule 55 1 * * * UTC
Coverage 05/26/2000–10/09/2026 Record Record Date Vuga Group Change Status Recency Days Research Attention Score Postoperative Adjuvant Chemotherapy in Early-stage Cervical Cancer That Not Meet Criteria of Adjuvant Therapeutic According to NCCN Guideline 01/26/2021 INTERVENTIONAL not-comparable 2,083.75 0 Improving Cognitive Function Through High-intensity Interval Training in Breast Cancer Patients Undergoing Chemotherapy 01/26/2021 INTERVENTIONAL not-comparable 2,083.75 0 PI-targeted PNE+MI Compared to BIOMEDICAL Education in BCS 01/29/2021 INTERVENTIONAL not-comparable 2,080.75 0 Local Antibiotics for Breast Implants 01/29/2021 INTERVENTIONAL not-comparable 2,080.75 0 Reduction in Number of Botox Injections for Urgency Urinary Incontinence 02/01/2021 INTERVENTIONAL not-comparable 2,077.75 0 Diagnostic, Therapeutic and Reproductive Aspects of Patients With Mullerian Anomalies (MULAN) 02/01/2021 OBSERVATIONAL not-comparable 2,077.75 0 Clinical Efficacy of Adjuvant Chemotherapy in Patients With Locally Advanced Cervical Cancer Who Did Not Meet the NCCN Guidelines for Adjuvant Treatment After NACT Combined With Surgery 02/02/2021 INTERVENTIONAL not-comparable 2,076.75 0 A Phase II Study to Explore the Safety, Tolerability, and Preliminary Antitumor Activity of Sitravatinib Plus Tislelizumab or Combination With Nab-paclitaxel in Patients With Locally Recurrent or Metastatic Triple Negative Breast Cancer (TNBC) 02/02/2021 INTERVENTIONAL not-comparable 2,076.75 0 Motor Cortical Neuromodulation in Women With Interstitial Cystitis/Bladder Pain Syndrome 02/02/2021 INTERVENTIONAL not-comparable 2,076.75 0 Continuous Monitoring and Management of Vaginal Health Via Multifunctional OCT/OCTA/OCE Endoscopy 02/04/2021 INTERVENTIONAL not-comparable 2,074.75 0 Comparison of Standard of Care Treatment With a Triplet Combination of Targeted Immunotherapeutic Agents 02/05/2021 INTERVENTIONAL not-comparable 2,073.75 0 Study to Evaluate the Impact of the Use of Alternative and Complementary Therapies on Therapeutic Adherence in Patients Treated With taMoxifen for Early Stage Breast Cancer 02/05/2021 INTERVENTIONAL not-comparable 2,073.75 0 Repeat Sentinel Lymph Node Biopsy in Ipsilateral Breast Tumor Recurrence 02/05/2021 INTERVENTIONAL not-comparable 2,073.75 0 Olaparib, Durvalumab and UV1 in Relapsed Ovarian Cancer 02/05/2021 INTERVENTIONAL not-comparable 2,073.75 0 IVF Versus Surgery for Endometriosis Related Infertility 02/08/2021 INTERVENTIONAL not-comparable 2,070.75 0 Blood and Urine HPVDNA as Minimally Invasive Biomarkers for Cervical Cancer Detection and Surveillance Following Treatment 02/08/2021 OBSERVATIONAL not-comparable 2,070.75 0 Microfluidics Versus Gradient Centrifugation Effect on Euploidy Rates 02/08/2021 INTERVENTIONAL not-comparable 2,070.75 0 Targeted Resection of Axillary Metastatic Lymph Nodes After Breast Cancer Neoadjuvant Chemotherapy 02/09/2021 INTERVENTIONAL not-comparable 2,069.75 0 Evaluation of a Phyto Aromatherapy Treatment in the Management of Recurrent Cystitis 02/10/2021 INTERVENTIONAL not-comparable 2,068.75 0 Immediate Versus Postponed Single Blastocyst Transfer in mNC-FET 02/10/2021 INTERVENTIONAL not-comparable 2,068.75 0 Impact of the Korea Early Childhood Home-visiting Intervention 02/11/2021 INTERVENTIONAL not-comparable 2,067.75 0 Neoadjuvant Therapy Study Guided by Drug Screening in Vitro for HER2 Positive Early Breast Cancer Patients 02/11/2021 INTERVENTIONAL not-comparable 2,067.75 0 Patient Related Outcomes for Gynecologic Radiation Oncology 02/15/2021 OBSERVATIONAL not-comparable 2,063.75 0 Culturally Based Brief Expressive Writing Intervention for the Improvement of Health in Chinese Immigrant Stage 0-III Breast Cancer Survivors, Writing to Heal Study 02/15/2021 INTERVENTIONAL not-comparable 2,063.75 0 Effect of Labetalol, Atenolol, and Nifedipine on Maternal Hemodynamics Measured by ICG in Early Pregnancy 02/16/2021 OBSERVATIONAL not-comparable 2,062.75 0 Local Tranexamic Acid During Vaginal Hysteractomy to Reduce Blood Loss 02/18/2021 INTERVENTIONAL not-comparable 2,060.75 0 Electrochemotherapy of Gynecological Cancers 02/18/2021 INTERVENTIONAL not-comparable 2,060.75 0 A Pilot Study of Revian Red All LED Cap as a Novel Treatment for Central Centrifugal Cicatricial Alopecia 02/21/2021 INTERVENTIONAL not-comparable 2,057.75 0 sFlt1/PlGF and Planned Delivery to Prevent Preeclampsia at Term. 02/23/2021 INTERVENTIONAL not-comparable 2,055.75 0 Research of Circulating Tumor Cells Released During Cervical Cancer Surgery 02/25/2021 INTERVENTIONAL not-comparable 2,053.75 0 In Utero Fetoscopic Repair Program for Sacral Myelomeningoceles and Mye-LDM 02/25/2021 INTERVENTIONAL not-comparable 2,053.75 0 A Prospective, Randomized Controlled Study of the Probiotics as Adjuvant Treatment for Bacterial Vaginosis 02/25/2021 INTERVENTIONAL not-comparable 2,053.75 0 MicroRNA Profiles in Triple Negative Breast Cancer 02/25/2021 INTERVENTIONAL not-comparable 2,053.75 0 Desara ® One Single Incision Sling 522 Study 02/26/2021 INTERVENTIONAL not-comparable 2,052.75 0 Comparison of LLETZ Versus LEEP for the Treatment of Cervical Dysplasia 02/26/2021 INTERVENTIONAL not-comparable 2,052.75 0 Radiation and TSR-042 (Dostarlimab) in People With Endometrial Cancer After They Receive Surgery 03/01/2021 INTERVENTIONAL not-comparable 2,049.75 0 Lenvatinib, Pembrolizumab, and Paclitaxel for Treatment of Recurrent Endometrial, Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer 03/04/2021 INTERVENTIONAL not-comparable 2,046.75 0 Effective Caregiving for Neonatal Abstinence Syndrome: Testing an Instructional Mobile Technology Platform for High-Risk Pregnant Women 03/05/2021 INTERVENTIONAL not-comparable 2,045.75 0 Early Prediction of Preeclampsia Using arteriaL Stiffness in High-risk prEgnancies 03/05/2021 OBSERVATIONAL not-comparable 2,045.75 0 Conservative Management of HSIL in Patients With Future Pregnancy Aspiration 03/05/2021 OBSERVATIONAL not-comparable 2,045.75 0 Modifying Progesterone and Estradiol Levels to Prevent Postpartum Cigarette Smoking Relapse and Reduce Secondhand Smoke Exposure in Infants and Children 03/05/2021 INTERVENTIONAL not-comparable 2,045.75 0 Alcohol Self-reporting During Pregnancy. AUTOQUEST Study. 03/08/2021 OBSERVATIONAL not-comparable 2,042.75 0 Neural Correlates of Stress and Perceived Control in Adolescent Depression 03/09/2021 INTERVENTIONAL not-comparable 2,041.75 0 Prehabilitation in Gynaecological Cancer Patients 03/09/2021 INTERVENTIONAL not-comparable 2,041.75 0 Quality of Life After Hysterectomy (AdenoQOL) 03/10/2021 OBSERVATIONAL not-comparable 2,040.75 0 Therapeutic Education and Nursing Support Program for Supportive Care, in Patients Treated With Hormone Therapy for Non-metastatic Breast Cancer 03/11/2021 INTERVENTIONAL not-comparable 2,039.75 0 Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer 03/12/2021 OBSERVATIONAL not-comparable 2,038.75 0 RESTORE - Study of AGN1 LOEP to Prevent Secondary Hip Fractures 03/12/2021 INTERVENTIONAL not-comparable 2,038.75 0 Prospective Evaluation of Breast-Conserving Surgery Alone in Low-Risk Ductal Carcinoma in Situ (DCIS) 03/15/2021 OBSERVATIONAL not-comparable 2,035.75 0 Labor Induction in Low-risk Nulliparous Women at 39 Weeks of Gestation to Reduce Cesarean: A Randomized Trial of Induction Versus Expectant Management in France (FRENCH-ARRIVE) 03/16/2021 INTERVENTIONAL not-comparable 2,034.75 0
Source U.S. National Library of Medicine, ClinicalTrials.gov API v2 · official record · retrieved 10/10/2026 · upstream last modified 10/10/2026
Licence United States government work; public domain unless the source record says otherwise. Source: U.S. National Library of Medicine
Required notice Study records are informational and do not provide diagnosis, treatment advice, or an assessment of individual risk. What we add We compute Vuga Group, Change Status, Recency Days, Research Attention Score using the documented compute method. · methodology